Denali Therapeutics Inc.

Denali Therapeutics is a biopharmaceutical company focused on developing innovative biotherapeutics that cross biological barriers, including the blood-brain barrier, to treat serious diseases such as neurodegenerative disorders and lysosomal storage diseases. Their proprietary TransportVehicle™ platform enables the delivery of novel therapies with the potential to transform patient outcomes.